GenMont Biotech Inc
TWSE:3164

Watchlist Manager
GenMont Biotech Inc Logo
GenMont Biotech Inc
TWSE:3164
Watchlist
Price: 18.45 TWD 1.93%
Market Cap: NT$1.6B

Operating Margin

11.2%
Current
Improving
by 1.5%
vs 3-y average of 9.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
11.2%
=
Operating Income
NT$43.9m
/
Revenue
NT$391.5m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
11.2%
=
Operating Income
NT$43.9m
/
Revenue
NT$391.5m

Peer Comparison

Country Company Market Cap Operating
Margin
TW
GenMont Biotech Inc
TWSE:3164
1.6B TWD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
387.5B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.5B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
168.8B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.3B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.2B USD
Loading...

Market Distribution

In line with most companies in Taiwan
Percentile
69th
Based on 1 045 companies
69th percentile
11.2%
Low
-21 347.1% — 0.7%
Typical Range
0.7% — 11.5%
High
11.5% — 698%
Distribution Statistics
Taiwan
Min -21 347.1%
30th Percentile 0.7%
Median 5%
70th Percentile 11.5%
Max 698%

GenMont Biotech Inc
Glance View

Market Cap
1.6B TWD
Industry
Biotechnology

Genmont Biotech Inc. engages in the research of new functional bacteria as well as the manufacturing and sale of probiotic powder. The company is headquartered in Tainan, Tainan. The company went IPO on 2003-06-12. The firm's major products include lactobacillus paracasei, lactobacillus rhamnosus, lactobacillus casei, lactobacillus plantarum, lactobacillus fermentum, lactobacillus salivarius, lactobacillus acidophilus, lactobacillus reuteri, lactobacillus brevis, lactobacillus bulgaricus, lactobacillus gasseri, lactobacillus johnsonii and others. The Company’s products are applied to enhance human immunity against dust allergy and digestive system health care. The firm distributes its products in domestic market and to overseas markets.

Intrinsic Value
36.79 TWD
Undervaluation 50%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
11.2%
=
Operating Income
NT$43.9m
/
Revenue
NT$391.5m
What is GenMont Biotech Inc's current Operating Margin?

The current Operating Margin for GenMont Biotech Inc is 11.2%, which is above its 3-year median of 9.7%.

How has Operating Margin changed over time?

Over the last 3 years, GenMont Biotech Inc’s Operating Margin has decreased from 19.7% to 11.2%. During this period, it reached a low of 2.2% on Dec 31, 2023 and a high of 19.7% on Aug 30, 2022.

Back to Top